Kommt jetzt der Durchbruch ?? - 500 Beiträge pro Seite
eröffnet am 16.09.09 13:20:10 von
neuester Beitrag 06.04.10 03:08:19 von
neuester Beitrag 06.04.10 03:08:19 von
Beiträge: 15
ID: 1.153.058
ID: 1.153.058
Aufrufe heute: 0
Gesamt: 1.072
Gesamt: 1.072
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 1 Stunde | 857 | |
| vor 1 Stunde | 796 | |
| gestern 18:41 | 629 | |
| heute 00:26 | 511 | |
| vor 1 Stunde | 499 | |
| gestern 22:49 | 417 | |
| gestern 17:47 | 337 | |
| vor 1 Stunde | 332 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.002,02 | -1,44 | 264 | |||
| 2. | 2. | 27,03 | -0,17 | 137 | |||
| 3. | 3. | 166,26 | -2,18 | 77 | |||
| 4. | Neu! | 479,00 | -5,71 | 69 | |||
| 5. | 6. | 0,1855 | -1,85 | 67 | |||
| 6. | 15. | 17,550 | -4,10 | 63 | |||
| 7. | 5. | 123,24 | +2,19 | 48 | |||
| 8. | 18. | 5,2900 | -1,89 | 43 |
Feedback
FDA Play on Imaging3 (OTC: IMGG.OB): Revolutionary Medical Device
Written by Michael Vlaicu
Sunday, 13 September 2009 17:34
Imaging3, Inc. (Public, OTC:IMGG) A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner).
Currently, medical imaging is met with challenges of long waits, lack of space, lack of mobility, and limited uses. However, for the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Thus, Imaging 3 looks to change all that. Saving time, saving lives and reducing costs. This technology will “set the standard for the next 10 years.” The following article was composed by StocksHaven Investments alongside Professor Philip Runfeldt, a Behavioral Analyst who has worked with Fortune 500 companies and major Universities throughout the Southeast.
About Imaging3 Inc. Imaging3, Inc. (Imaging3) is a medical device manufacturer, distributor and third-party service provider. The Company has developed a technology, known as Dominion, which utilizes photo-fluoroscopy to produce three dimensional (3D) medical diagnostic images in real time. Imaging3 is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms.
The company was founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. According to the companies undisputed claims NO OTHER device provides 3D real time images. This means saving time and that accounts to saving lives. At a fraction of the cost for devices that do less it can be used in emergency rooms and urology procedures. Doctors want to see 3D images allowing for depth and direction perception whether performing diagnostic or interventional procedures. They now must utilize 2Dimaging that doesn’t allow for this.
artikel aus biomedreports...
Written by Michael Vlaicu
Sunday, 13 September 2009 17:34
Imaging3, Inc. (Public, OTC:IMGG) A new and radical medical device from Imaging3 Inc. (OTC:IMGG) is ready to set the standard, and revolutionize the way we look at X-ray, MRI and CT scans. Imaging 3 is currently awaiting FDA approval on their DViS (Dominion Volumetric Imaging Scanner).
Currently, medical imaging is met with challenges of long waits, lack of space, lack of mobility, and limited uses. However, for the first time ever, health-care workers will be able to instantly view 3D, high-resolution images of virtually any part of the human body. Thus, Imaging 3 looks to change all that. Saving time, saving lives and reducing costs. This technology will “set the standard for the next 10 years.” The following article was composed by StocksHaven Investments alongside Professor Philip Runfeldt, a Behavioral Analyst who has worked with Fortune 500 companies and major Universities throughout the Southeast.
About Imaging3 Inc. Imaging3, Inc. (Imaging3) is a medical device manufacturer, distributor and third-party service provider. The Company has developed a technology, known as Dominion, which utilizes photo-fluoroscopy to produce three dimensional (3D) medical diagnostic images in real time. Imaging3 is also a remanufacturer of C-arms. The Company offers new, demonstration, remanufactured, refurbished and pre-owned systems in all price ranges from every manufacturer, including OEC, General Electric (GE), ISI, Philips, Siemens, FluoroScan, XiScan and Ziehm. The Company supplies full-size, compact and mini C-arms.
The company was founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. According to the companies undisputed claims NO OTHER device provides 3D real time images. This means saving time and that accounts to saving lives. At a fraction of the cost for devices that do less it can be used in emergency rooms and urology procedures. Doctors want to see 3D images allowing for depth and direction perception whether performing diagnostic or interventional procedures. They now must utilize 2Dimaging that doesn’t allow for this.
artikel aus biomedreports...
aktie hat gestern in usa schon sehr stark zugelegt...
sicherlich gepusht durch diverse artikel in biomedreports -
wird ja doch vielfach als quelle genutzt!
sicherlich gepusht durch diverse artikel in biomedreports -
wird ja doch vielfach als quelle genutzt!
kennt jemand schon länger diese firma??
bin selbst noch nicht investiert - OTC-immer
mit vorsicht zu geniesen
überlege heute eine evtl. kleine position aufzubauen...
bin selbst noch nicht investiert - OTC-immer
mit vorsicht zu geniesen
überlege heute eine evtl. kleine position aufzubauen...
was ist los - keiner interessiert???
so schlecht war der tipp doch nicht - +60% z.zt. in usa
so schlecht war der tipp doch nicht - +60% z.zt. in usa
Bin mit 30K heute sofort zu Beginn eingestiegen, jetzt aber in der Arbeit und habe keinen Chart.
Könntest du bitte einen solchen reinstellen?
Im übrigen ist die Technologie umwerfend und revolutionär, ganz besonders wichtig- sie soll offensichtlich Kosten sparen.
Bis Freitag oder kommenden Montag ist zumindest eine Meldung von Seiten FDA laut Bericht vor einigen Tagen zu erwarten, hoffentlich das Approval selbst.
Hoffe auch gleichzeitig, daß hier nicht so eine Warterei bzw. Irritationen wie bei Nephros auftreten.
Viel Glück!
Mfg Vent
Könntest du bitte einen solchen reinstellen?
Im übrigen ist die Technologie umwerfend und revolutionär, ganz besonders wichtig- sie soll offensichtlich Kosten sparen.
Bis Freitag oder kommenden Montag ist zumindest eine Meldung von Seiten FDA laut Bericht vor einigen Tagen zu erwarten, hoffentlich das Approval selbst.
Hoffe auch gleichzeitig, daß hier nicht so eine Warterei bzw. Irritationen wie bei Nephros auftreten.
Viel Glück!
Mfg Vent
Trading Spotlight
kleine posi zulegen. muss jetzt aber wieder weg.
bis heute abend
bis heute abend
war wohl zu geizig, habe keine bekommen
werd heute auch nochmal einkaufen...
bleibe aber in überschaubaren positionen - otc eben
bleibe aber in überschaubaren positionen - otc eben
hab leider keine ausführung bekommen
,
trotz zigmaligem unterschreiten meines limits...kenn ich
OTC ist und bleibt eine "sCH...börse"...
aktie/company ist o.k.,
wünsche allen investierten
gute gewinne...
kurs nachziehen mach ich nicht,
der makler soll seinen dreck behalten
,trotz zigmaligem unterschreiten meines limits...kenn ich
OTC ist und bleibt eine "sCH...börse"...
aktie/company ist o.k.,
wünsche allen investierten
gute gewinne...
kurs nachziehen mach ich nicht,
der makler soll seinen dreck behalten
Hallo!
Halte diese Aktie schon sehr lange
wird seit das was passiert(FDA)
Grüße
Halte diese Aktie schon sehr lange
wird seit das was passiert(FDA)
Grüße
Antwort auf Beitrag Nr.: 38.094.871 von UH1d am 01.10.09 14:33:02Eigentlich verrückt, dass hier scheinbar niemand dabei ist ! Ich bin bei 42 USCent rein und habe allerdings mit der Hälfte vor ca. 3 Wochen "Cash" gemacht, mit 70%Gewinn. Ja jetzt wären es allerdings ein paar schöne Dollars mehr... Aber diese Aktie hat noch mehr Potential, wenn immer mehr diese revolutionäre Technik für die Medizin entdecken ! Nach oben sind kaum Grenzen gesetzt und Gewinnmitnahmen sollten zum Kauf genutzt werden ! Meine persönliche Einschätzung.
netter wert hier 
bin mit 0.58 eingestiegen
glück auf
bin mit 0.58 eingestiegen
glück auf
das ding geht auf zu alten höhen
einsteigen alle der zug fährt los
einsteigen alle der zug fährt los
ausbruch nach oben 
News news News
Press Release Source: Imaging3, Inc. On Monday April 5, 2010, 7:21 pm EDT
BURBANK, CA--(Marketwire - 04/05/10) - Imaging3™, Inc. (OTC.BB:IMGG - News), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced that today, Monday April 5, 2010, Dean Janes, CEO of Imaging3, Inc., submitted the company's latest response to the FDA.
If you have any questions, please feel free to contact us by e-mail or directly by calling (800) 900-9729.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at http://www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company
http://finance.yahoo.com/news/Imaging3-Announces-FDA-iw-2029…
Press Release Source: Imaging3, Inc. On Monday April 5, 2010, 7:21 pm EDT
BURBANK, CA--(Marketwire - 04/05/10) - Imaging3™, Inc. (OTC.BB:IMGG - News), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced that today, Monday April 5, 2010, Dean Janes, CEO of Imaging3, Inc., submitted the company's latest response to the FDA.
If you have any questions, please feel free to contact us by e-mail or directly by calling (800) 900-9729.
About Imaging3
Imaging3, Inc., founded in 1993, is a leading provider of advanced technology medical imaging devices. The Company has developed a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company's website at http://www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company
http://finance.yahoo.com/news/Imaging3-Announces-FDA-iw-2029…
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 53 | ||
| 29 | ||
| 19 | ||
| 18 | ||
| 16 | ||
| 16 | ||
| 15 | ||
| 14 | ||
| 14 | ||
| 14 |
| Wertpapier | Beiträge | |
|---|---|---|
| 12 | ||
| 12 | ||
| 11 | ||
| 11 | ||
| 11 | ||
| 10 | ||
| 10 | ||
| 9 | ||
| 9 | ||
| 9 |
